{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-332939","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2026-08-04T20:30:17+00:00","discovered_at":"2026-08-04T20:32:05.387939+00:00","generated_at":"2026-08-04T20:32:30.902148+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Plus Therapeutics changes name to Cerenome, Inc.; trading symbol changes to CNSY","bullets":["Name change from Plus Therapeutics, Inc. to Cerenome, Inc. effective August 3, 2026.","Common stock now trades on Nasdaq under symbol CNSY, effective August 3, 2026.","CUSIP number remains unchanged despite the name and symbol change.","Bylaws amended to reflect the new corporate name, filed as Exhibit 3.2."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-332939","json":"https://secwatch.observer/filing/0001193125-26-332939.json","markdown":"https://secwatch.observer/filing/0001193125-26-332939.md","text":"https://secwatch.observer/filing/0001193125-26-332939.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526332939/0001193125-26-332939-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526332939/pstv-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:32:30.902148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}